(3R,4S,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol
![BK56N3 | 1030825-21-8 | (3R,4S,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol](https://qncdn.chemcd.cn/alchemypharm/AP10805.png "BK56N3 | 1030825-21-8 | (3R,4S,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol")
Catalog No.: BK56N3
CAS.RN：1030825-21-8
Molecular Formula: C25H27FO6S
Molecular Weight: 474.54 g/mol
Purity: NLT 98%
Intermediates of Canagliflozin
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA37J0 | Canagliflozin API | 842133-18-0 |
| BK1Z8R | Thiophene, 2-[(5-bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)- | 1030825-20-7 |
| BK7Q8G | D-Gluconic acid, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, δ-lactone | 32384-65-9 |
| BK9Y1E | Thiophene, 2-(4-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]- | 898566-17-1 |
| BK56N3 | (3R,4S,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol | 1030825-21-8 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
